In glioblastoma models, phloridzin improves the cytotoxic effects of temozolomide (TMZ) by suppressing PI3K/AKT/mTOR signaling, leading to increased apoptosis (Hou et al. 2025). This evidence concerns the gene AKT1 and glioblastoma.